National reach Position Central Rexall Drugs as a nationwide compounding leader serving all 50 states and Washington D.C., highlighting capabilities to supply customized medications to physicians and hospitals beyond the local market.

Accredited trust Leverage PCAB accreditation and memberships with UCM, PCCA, and IACP to reassure prospective distributors and hospital buyers about quality standards, regulatory compliance, and best practices in compounding.

Multi-state licensing Emphasize multi-state licensure as a selling point for distributors and healthcare systems seeking compliant partners capable of national scale without regional licensing friction.

Community heritage Capitalize on a 120-year family-owned legacy and personalized service model to differentiate from larger chains, appealing to hospitals and clinics valuing trust, continuity of care, and patient-centric compounding.

Growth opportunities Target expansion into non-sterile compounded product lines for hospitals and specialty clinics, and engage distributors and sales pros to broaden reach in the hospital channel and physician networks.